BXP — Beximco Pharmaceuticals Share News
0.000.00%
- £196.29m
 - £244.13m
 - BDT44.39bn
 
- 93
 - 96
 - 78
 - 100
 
REG - Beximco Pharmaceut - Statement re: media comment
AnnouncementREG - Beximco Pharmaceut - Notice of AGM
AnnouncementREG - Beximco Pharmaceut - Results for First Quarter Ended 30 September 2021
AnnouncementREG - Beximco Pharmaceut - Launch of world’s first generic molnupiravir
AnnouncementREG - Beximco Pharmaceut - Results for the year ended 30 June 2021
AnnouncementREG - Beximco Pharmaceut - Notification of Preliminary Results and AGM
AnnouncementREG - Beximco Pharmaceut - Update on the supply of COVID-19 vaccine
AnnouncementREG - Beximco Pharmaceut - Completion of Sanofi Bangladesh Acquisition
AnnouncementREG - Beximco Pharmaceut - Sanofi Bangladesh Share Purchase Agreement signed
AnnouncementREG - Beximco Pharmaceut - Acquisition Approved by Bangladesh Bank
AnnouncementREG - Beximco Pharmaceut - Statement re: media comment
AnnouncementRCS - Beximco Pharmaceut - FDA approval for muscle relaxant drug Baclofen
AnnouncementREG - Beximco Pharmaceut - Update on the supply of COVID-19 vaccine
AnnouncementREG - Beximco Pharmaceut - Q3 Financial Results
AnnouncementREG - Beximco Pharmaceut - Update on the supply of COVID-19 vaccine
AnnouncementREG - Beximco Pharmaceut - Second Price Monitoring Extn
AnnouncementREG - Beximco Pharmaceut - Price Monitoring Extension
AnnouncementREG - Beximco Pharmaceut - Second Price Monitoring Extn
AnnouncementREG - Beximco Pharmaceut - Price Monitoring Extension
Announcement